EFFECT OF MIRIKIZUMAB ON INFLAMMATORY BIOMARKERS IN A PHASE 2 STUDY OF PATIENTS WITH CROHN'S DISEASE

Geert R. D'Haens  ¹     Stefan Schreiber  ²     Edouard Louis  ³     Bruce E. Sands  ⁴     Elisa Gomez Valderas  ⁵     Debra Miller  ⁵     Noah Agada  ⁵     April Naegeli  ⁵     Paul Pollack  ⁵     Jochen Schmitz  ⁵     Janneke van der Woude  ⁶     Jaroslaw Kierkus  ⁷     William Sandborn  ^8    
1 University of Amsterdam Academic Medical Center, Amsterdam, Netherlands
² Kiel University Institute of Clinical Molecular Biology, Kiel, Germany
³ University Hospital CHU Liege, Liege, Belgium
⁴ Icahn School of Medicine at Mount Sinai, New York, United States
⁵ Eli Lilly and Company, Indianapolis, United States
⁶ Erasmus University Medical Center, Rotterdam, Netherlands
⁷ Children's Memorial Health Institute, Warsaw, Poland
⁸ University of California San Diego, La Jolla, United States

Session
IBD Clinical III

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)